XALACOM

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Ecuador, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Nigeria, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug XALACOM contains a combination of these active pharmaceutical ingredients (APIs):

1	Latanoprost UNII 6Z5B6HVF6O - LATANOPROST
	The active substance latanoprost, a prostaglandin F2α analogue, is a selective prostanoid FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humour. Reduction of the IOP in man starts about three to four hours after administration and maximum effect is reached after eight to twelve hours.
	Read more about Latanoprost
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5553G, 8895E
BR	Câmara de Regulação do Mercado de Medicamentos	552820060069317
CA	Health Products and Food Branch	02246619
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00417220, 00417237, 01246588, 01246594, 01246648, 02140107, 02140142, 02725351, 02725368, 02725374, 03259394, 03420010, 09542895, 09542903, 10418166, 13743955, 13749449, 13749455, 13824955, 13832541, 15266399, 16698155
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29525-12-10
EE	Ravimiamet	1088254, 1393062
ES	Centro de información online de medicamentos de la AEMPS	64187
FR	Base de données publique des médicaments	63781007
GB	Medicines & Healthcare Products Regulatory Agency	139796, 147621, 164560, 36431, 374017, 377100
HK	Department of Health Drug Office	49378
HR	Agencija za lijekove i medicinske proizvode	HR-H-427502884
IE	Health Products Regulatory Authority	53908, 73590
IL	מִשְׂרַד הַבְּרִיאוּת	4591
IT	Agenzia del Farmaco	035402015
JP	医薬品医療機器総合機構	1319817Q1020
LT	Valstybinė vaistų kontrolės tarnyba	1003991
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	368M2001
NG	Registered Drug Product Database	A4-2253
Switch country to Nigeria in order to find specific presentations of XALACOM
NL	Z-Index G-Standaard	14696037
NL	Z-Index G-Standaard, PRK	60526
PL	Rejestru Produktów Leczniczych	100122906
SG	Health Sciences Authority	11922P
TN	Direction de la Pharmacie et du Médicament	4133011, 4133012
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532618368
ZA	Health Products Regulatory Authority	36/15.4/0043